AU2009242122B2 - Pegylated recombinant human growth hormone compounds - Google Patents

Pegylated recombinant human growth hormone compounds

Info

Publication number
AU2009242122B2
AU2009242122B2 AU2009242122A AU2009242122A AU2009242122B2 AU 2009242122 B2 AU2009242122 B2 AU 2009242122B2 AU 2009242122 A AU2009242122 A AU 2009242122A AU 2009242122 A AU2009242122 A AU 2009242122A AU 2009242122 B2 AU2009242122 B2 AU 2009242122B2
Authority
AU
Australia
Prior art keywords
growth hormone
recombinant human
human growth
pegylated recombinant
hormone compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2009242122A
Other versions
AU2009242122A1 (en
Inventor
Ulrich Hersel
Susanne Kindermann
Torben Lessmann
Grethe Noerskov Rasmussen
Harald Rau
Kennett Sprogoe
Thomas Wegge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ascendis Pharma Endocrinology Division AS
Original Assignee
Ascendis Pharma Growth Disorders AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP08155408A external-priority patent/EP2113256A1/en
Application filed by Ascendis Pharma Growth Disorders AS filed Critical Ascendis Pharma Growth Disorders AS
Priority claimed from PCT/EP2009/055194 external-priority patent/WO2009133137A2/en
Publication of AU2009242122A1 publication Critical patent/AU2009242122A1/en
Assigned to ASCENDIS PHARMA A/S reassignment ASCENDIS PHARMA A/S Amend patent request/document other than specification (104) Assignors: ASCENDIS PHARMA AS
Assigned to ASCENDIS PHARMA GROWTH DISORDERS DIVISION A/S reassignment ASCENDIS PHARMA GROWTH DISORDERS DIVISION A/S Request for Assignment Assignors: ASCENDIS PHARMA A/S
Priority to AU2014200350A priority Critical patent/AU2014200350B2/en
Application granted granted Critical
Publication of AU2009242122B2 publication Critical patent/AU2009242122B2/en
Assigned to ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S reassignment ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S Request to Amend Deed and Register Assignors: ASCENDIS PHARMA GROWTH DISORDERS DIVISION A/S
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2009242122A 2008-04-29 2009-04-29 Pegylated recombinant human growth hormone compounds Active AU2009242122B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2014200350A AU2014200350B2 (en) 2008-04-29 2014-01-21 Pegylated recombinant human growth hormone compounds

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP08155408A EP2113256A1 (en) 2008-04-29 2008-04-29 PEGylated rhGH compounds
EP08155408.1 2008-04-29
EP08162865 2008-08-22
EP08162865.3 2008-08-22
EP08167289 2008-10-22
EP08167289.1 2008-10-22
PCT/EP2009/055194 WO2009133137A2 (en) 2008-04-29 2009-04-29 Pegylated recombinant human growth hormone compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2014200350A Division AU2014200350B2 (en) 2008-04-29 2014-01-21 Pegylated recombinant human growth hormone compounds

Publications (2)

Publication Number Publication Date
AU2009242122A1 AU2009242122A1 (en) 2009-11-05
AU2009242122B2 true AU2009242122B2 (en) 2014-04-24

Family

ID=

Similar Documents

Publication Publication Date Title
IL228673A0 (en) Pegylated recombinant human growth hormone compounds
HK1223946A1 (en) Biologically active peptides
SG10201608059VA (en) Recombinant vwf formulations
EP2298801A4 (en) Glycosylated glp-1 peptide
HRP20130414T1 (en) Lyophilized recombinant vwf formulations
HK1244426A1 (en) Therapeutic protein formulations
EP2376099A4 (en) Yl-based insulin-like growth factors exhibiting high activity at the insulin receptor
IL202225A0 (en) Growth hormone fusion proteins
ZA201000283B (en) Reinigung pegylierter polypeptide
EP2393830B8 (en) Grass peptides for vaccine
ZA201105419B (en) Stable growth hormone compounds
EP2133090A4 (en) Growth hormone secretion stimulator
EP2310035A4 (en) Fibroblast growth factor (fgf) analogs and uses thereof
WO2009151689A9 (en) Improved beta thymosin fragments
EP2254901A4 (en) Therapeutic peptides
AU2009242122B2 (en) Pegylated recombinant human growth hormone compounds
IL203073A0 (en) Modified growth hormone polypeptides
AU2008900848A0 (en) Therapeutic peptides
GB0600114D0 (en) Growth hormone variations
AU2008906271A0 (en) Cathode Harvesting
AU2007900058A0 (en) Recombinant Antibodies
AU2007902486A0 (en) Insulin formulations
GB0605899D0 (en) Placental growth factor
AU2008901028A0 (en) Slide-on canopy
AU2008902694A0 (en) Crop Harvester